Cargando…
Pharmacological Targets in Chronic Heart Failure with Reduced Ejection Fraction
Heart failure management has been repeatedly reviewed over time. This strategy has resulted in improved quality of life, especially in patients with heart failure with reduced ejection fraction (HFrEF). It is for this reason that new mechanisms involved in the development and progression of heart fa...
Autores principales: | Moloce, Maria-Angela, Costache, Irina-Iuliana, Nicolae, Ana, Onofrei Aursulesei, Viviana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394280/ https://www.ncbi.nlm.nih.gov/pubmed/35892914 http://dx.doi.org/10.3390/life12081112 |
Ejemplares similares
-
Cardiac Reverse Remodeling in Ischemic Heart Disease with Novel Therapies for Heart Failure with Reduced Ejection Fraction
por: Leancă, Sabina Andreea, et al.
Publicado: (2023) -
Anticoagulation in chronic kidney disease: from guidelines to clinical practice
por: Aursulesei, Viviana, et al.
Publicado: (2019) -
The Novel Perspectives Opened by ST2 in the Pandemic: A Review of Its Role in the Diagnosis and Prognosis of Patients with Heart Failure and COVID-19
por: Miftode, Radu-Stefan, et al.
Publicado: (2021) -
Emerging Pharmacologic Therapies for Heart Failure With Reduced Ejection Fraction
por: Chaudhary, Ammar G., et al.
Publicado: (2021) -
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fraction
por: Stolfo, Davide, et al.
Publicado: (2023)